markdrug

182 results found.

Top Stocks matching your search for "mark drug"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

- Timo grimmer is in the team - All endpoints of ... See more

Mar, 15, 2023

The drug shows it works as is!

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 19, 2023

Clearly the drug is working !

Mar, 8, 2023

That’s a lot of money to invest multiple times on ... See more

Motley Fool
Discover Your Wealth Potential with Stock Advisor

The Motley Fool Stock Advisor has a track record that speaks for itself, with average recommendations that have returned over 542%*. Act now so you can start investing smarter, not harder.

*As of October 2023$79 is an introductory price for new members only. 60% discount based on the current list price of Stock Advisor of $199/year. Membership will renew annually at the then current list price.
02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
HEPA

Hepion Pharmaceuticals Inc

-16.85%

$0.86 - $0.72

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 24, 2023

The only thing im sure about with this company is ... See more

Feb, 1, 2023

This makes Rencofilstat a promising candidate for ... See more

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

- Timo grimmer is in the team - All endpoints of the clinical trial were reached I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

Mar, 15, 2023

The drug shows it works as is!

Feb, 24, 2023

we have a drug, even many drugs, good for so many indications, to become a giant pharma, we are about to get billions in revenues.

Feb, 14, 2023

$AVXL The improvements in the drug arm cannot be lucky. .

Feb, 5, 2023

Our drug has no side effects.

Jan, 31, 2023

I'm looking forward to seeing the long term AD data on ANVS and have the feeling it's going to end up being the best in class AD treatment as well.

Jan, 17, 2023

Do not listen to any FUD this drug is the real deal.

Jan, 17, 2023

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

Jan, 12, 2023

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 19, 2023

Clearly the drug is working !

Mar, 8, 2023

That’s a lot of money to invest multiple times on a promising treatment 🚀

Feb, 6, 2023

This is the ONLY drug in HISTORY to improve cognition after 12 months.

Feb, 1, 2023

$SAVA A safe drug that impacts both neurodegeneration and neuroinflammation is going to have potential treating other CNS diseases.

Jan, 30, 2023

Proper stock and proper drug doesn't smell like a scam.

Jan, 13, 2023

Deeply appreciative of the treatment that SAVA is working to deliver,

Jan, 11, 2023

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

Jan, 11, 2023

I’m holding long term because I truly believe this is the first effective Alz treatment to date.

Jan, 11, 2023

$SAVA Data is good and the drug works.

HEPA

Hepion Pharmaceuticals Inc

-16.85%

$0.86 - $0.72

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 24, 2023

The only thing im sure about with this company is that its drug has great potential

Feb, 1, 2023

This makes Rencofilstat a promising candidate for the treatment of a variety of diseases, including thromboembolic disorders, sepsis, and cancer.

Jan, 18, 2023

if this is truly a 4B, 5B or more mkt cap drug it’ll ultimately end up with a SP in the hundreds of dollars (assuming RS goes through) and everyone will be happy in the long run.

Jan, 18, 2023

Despite everything, the fact remains that absolutely nobody has come up with anything substantially bad to report about this amazing drug.

Jan, 18, 2023

MIRACLE DRUG CHEAP SHARES HERE $HEPA! !

Jan, 13, 2023

For any investor, being able to buy the company below cash value while getting the wonder drug, Rencofilstat, for free is a VERY attractive investment proposition.

Jan, 13, 2023

That drug has been proven to be safe to be used in tandem with any other known drugs.

Jan, 12, 2023

$HEPA this drug is game changer in hepatology!

Jan, 11, 2023

2023 is going to be highlighted with a continuous cascade of amazingly positive PR’s confirming the fact (already documented in 300+ early clinical studies), that Rencofilstat is truly a Wonder Drug to be celebrated, with an extraordinarily large TAM.